United States - English - NLM (National Library of Medicine)

dr. althea - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - dr. althea premium intensive essence mask is a fast absorbing moisturizer that instantly hydrates the skin and improves the overall radiance. it restores elasticity and suppleness and gives a stunning glow on the face. [how to use] after prepping cleansed face with a toner, apply an appropriate amount of essence mask on the face and gently massage it until it is fully absorbed into the skin. considering the skin restoring cycle and for full benefits, use 3~4 pouches a week for four consecutive weeks.

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - omeprazole 20mg;   - modified release capsule - 20 mg - active: omeprazole 20mg   excipient: crospovidone gelatin hypromellose isopropyl alcohol magnesium stearate mannitol meglumine methacrylic acid - ethyl acrylate copolymer opacode black s-1-27794 poloxamer povidone purified water triethyl citrate

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - teriflunomide, quantity: 14 mg - tablet - excipient ingredients: maize starch; magnesium stearate; hyprolose; silicon dioxide; lactose monohydrate; sodium starch glycollate; titanium dioxide; hypromellose; macrogol 6000; iron oxide yellow; indigo carmine aluminium lake - teriflunomide dr.reddy's is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - posaconazole, quantity: 100 mg - tablet, modified release - excipient ingredients: croscarmellose sodium; macrogol 400; hypromellose acetate succinate; silicon dioxide; triacetin; purified talc; hyprolose; iron oxide red; magnesium stearate; titanium dioxide; microcrystalline cellulose; hypromellose - posaconazole dr.reddy's (posaconazole) is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ,? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ,? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy. ,posaconazole dr.reddy's is also indicated for the: ,? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.